Arkolith/Insider Trading/FNCH/Form 4

Smisek Jeffery A

DirectorFinch Therapeutics Group, Inc. (FNCH) · full profile →Form 4 · filed Nov 27, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2023Sell(S)1K$3.64$5K7K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-066155) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML